| Literature DB >> 32244494 |
Andrea Rossnerova1, Katerina Honkova1, Daniela Pelclova2, Vladimir Zdimal3, Jaroslav A Hubacek4, Irena Chvojkova1, Kristyna Vrbova5, Pavel Rossner5, Jan Topinka1, Stepanka Vlckova2, Zdenka Fenclova2, Lucie Lischkova2, Pavlina Klusackova2, Jaroslav Schwarz3, Jakub Ondracek3, Lucie Ondrackova3, Martin Kostejn3, Jiri Klema6, Stepanka Dvorackova7.
Abstract
The risk of exposure to nanoparticles (NPs) has rapidly increased during the last decade due to the vast use of nanomaterials (NMs) in many areas of human life. Despite this fact, human biomonitoring studies focused on the effect of NP exposure on DNA alterations are still rare. Furthermore, there are virtually no epigenetic data available. In this study, we investigated global and gene-specific DNA methylation profiles in a group of 20 long-term (mean 14.5 years) exposed, nanocomposite, research workers and in 20 controls. Both groups were sampled twice/day (pre-shift and post-shift) in September 2018. We applied Infinium Methylation Assay, using the Infinium MethylationEPIC BeadChips with more than 850,000 CpG loci, for identification of the DNA methylation pattern in the studied groups. Aerosol exposure monitoring, including two nanosized fractions, was also performed as proof of acute NP exposure. The obtained array data showed significant differences in methylation between the exposed and control groups related to long-term exposure, specifically 341 CpG loci were hypomethylated and 364 hypermethylated. The most significant CpG differences were mainly detected in genes involved in lipid metabolism, the immune system, lung functions, signaling pathways, cancer development and xenobiotic detoxification. In contrast, short-term acute NP exposure was not accompanied by DNA methylation changes. In summary, long-term (years) exposure to NP is associated with DNA epigenetic alterations.Entities:
Keywords: 850K microarray; CpG sites; DNA methylation; epigenetic adaptation; human; nanoparticles; occupational exposure
Mesh:
Year: 2020 PMID: 32244494 PMCID: PMC7177382 DOI: 10.3390/ijms21072420
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Scanning Mobility Particle Sizer (SMPS) + Aerodynamic Particle Sizer (APS) concentration in wider size bins related to (a) metal active gas (MAG) welding process in workshop 1; (b) grinding and milling processes in workshop 2; (c) background, basement; (d) background, ground floor.
Total number concentrations of five PM fractions (nano to 10 µm) per cm3 measured by on-line monitoring (SMPS and APS) during the shift related to the individual working processes including backgrounds.
|
| ||||||
|---|---|---|---|---|---|---|
| Processes | 1. | 2. | 3. | 4. | 5. | Total |
| Backgrounds | <25 nm | 25–100 nm | 100 nm–1 µm | 1−2.5 µm | 2.5−10 µm | <10 µm |
| MAG welding | 1680 | 3840 | 3790 | 1.1 | 0.215 | 9311 |
| Grinding and Milling | 9700 | 16400 | 3040 | 16 | 2.53 | 29159 |
| Background, basement | 574 | 6260 | 2370 | 0.42 | 0.078 | 9204 |
| Background, ground floor | 92.5 | 3550 | 1680 | 0.232 | 0.006 | 5323 |
Abbreviations: SMPS, scanning mobility particle sizer; APS; aerodynamic particle sizer; MAG, metal active gas.
Figure 2Pre-shift and post-shift levels of % 5-mC in exposed and control groups.
Figure 3The impact of the nanoparticle exposure on the DNA methylation pattern; analyzed by PCA. (a) Comparison between exposed pre-shift and exposed post-shift groups. (b) Comparison between control pre-shift and control post-shift groups. (c) Comparison between exposed pre-shift and control pre-shift groups. (d) Comparison between exposed post-shift and control post-shift groups.
Figure A1Hierarchical clustering analysis of all 705 differentially methylated CpG loci in exposed und control groups. Columns represent individual samples (exposed, purple; controls, green); methylation intensity in individual CpG sites are in rows.
Figure 4Hierarchical clustering analysis of the most differentially methylated CpG loci in the exposed and control group. Columns represent individual samples (exposed, purple; controls, green); methylation intensities in individual CpG sites identified by cg numbers are in rows.
Overview of information related to the 14 most differentially methylated CpG loci (bold) in the exposed group when compared to the controls including all other significant results in the same gene.
| # Chrom. | CpG Locus | Island | Gene | Relevance or | log FC | ||
|---|---|---|---|---|---|---|---|
| #1 |
| Open Sea |
| Signaling pathways | 1.645 | 1.30 × 10−7 | 0.002 |
|
| Open Sea | “ | Breast carcinoma | 1.647 | 2.20 × 10−7 | 0.003 | |
| cg00588342 | Open Sea | “ | 0.294 | 1.44 × 10−5 | 0.027 | ||
| cg26347746 | Open Sea | “ | 0.863 | 2.61 × 10−7 | 0.003 | ||
| cg25270774 | Open Sea | “ | 1.233 | 3.25 × 10−7 | 0.003 | ||
| cg05044291 | Open Sea | “ | 1.282 | 3.11 × 10−7 | 0.003 | ||
| #6 |
| N Shore |
| Regulation | −1.813 | 1.77 × 10−6 | 0.009 |
|
| N Shore | “ | Ankylosing | −1.699 | 2.34 × 10−7 | 0.003 | |
|
| N Shore | “ | spondylitis | −1.651 | 3.21 × 10−7 | 0.003 | |
| cg23595396 | N Shore | “ | Alopecia | −1.059 | 7.77 × 10−7 | 0.006 | |
| cg24023453 | N Shore | “ | Asthma | −0.833 | 1.24 × 10−6 | 0.008 | |
| Lung carcinoma | |||||||
| Blood cells count | |||||||
| #7 |
| N Shelf |
| Hypothyroidism | 3.111 | 3.97 × 10−8 | 0.001 |
| #10 |
| N Shore |
| Signaling pathways | −1.584 | 4.21 × 10−9 | <0.001 |
|
| N Shore | “ | Kinase activity | −1.579 | 3.42 × 10−8 | 0.001 | |
|
| N Shore | “ | Reg. cell prolif. | −1.558 | 4.18 × 10−8 | 0.001 | |
|
| Open Sea | “ | Apoptosis | 1.659 | 7.81 × 10−8 | 0.001 | |
| cg11430259 | N Shore | “ | Lung carcinoma | −1.442 | 3.74 × 10−7 | 0.004 | |
| cg02210151 | N Shore | “ | Brest carcinoma | −1.152 | 4.66 × 10−8 | 0.001 | |
| cg22633036 | N Shore | “ | Colorectal cancer | −1.117 | 2.63 × 10−7 | 0.003 | |
| cg13437682 | N Shore | “ | Blood pressure | −1.025 | 1.99 × 10−8 | <0.001 | |
| cg16961769 | Open Sea | “ | −0.843 | 1.41 × 10−6 | 0.008 | ||
| cg12669518 | Open Sea | “ | −0.820 | 1.11 × 10−7 | 0.002 | ||
| cg17681491 | N Shore | “ | −0.791 | 1.35 × 10−8 | <0.001 | ||
| cg14968358 | Open Sea | “ | −0732 | 3.37 × 10−5 | 0.043 | ||
| cg23248910 | Open Sea | “ | −0.719 | 3.71 × 10−7 | 0.003 | ||
| cg13707729 | Open Sea | “ | −0.486 | 1.02 × 10−5 | 0.023 | ||
| cg17723924 | Open Sea | “ | −0.405 | 5.75 × 10−6 | 0.017 | ||
| cg25833171 | Open Sea | “ | −0.351 | 2.71 × 10−5 | 0.038 | ||
| cg12990750 | Open Sea | “ | −0.317 | 4.31 × 10−5 | 0.048 | ||
| cg07344086 | Open Sea | “ | −0.261 | 2.53 × 10−5 | 0.037 | ||
| cg25409939 | Open Sea | “ | 0.627 | 6.14 × 10−6 | 0.018 | ||
| cg03552039 | Open Sea | “ | 0.634 | 3.85 × 10−7 | 0.003 | ||
| cg17280705 | Open Sea | “ | 0.638 | 1.37 × 10−5 | 0.027 | ||
| cg08195415 | Open Sea | “ | 0.665 | 5.48 × 10−6 | 0.017 | ||
| cg08899523 | Open Sea | “ | 1.452 | 6.86 × 10−8 | 0.001 | ||
|
| Open Sea | out | −1.778 | 1.07 × 10−8 | <0.001 | ||
| #11 |
| S Shore |
| Signaling pathways | −3.843 | 1.55 × 10−7 | 0.002 |
| cg16733419 | N Shelf | “ | Proinf. cytokines↑ | −0.339 | 2.25 × 10−5 | 0.034 | |
| Hemoglobin level | |||||||
| BMI | |||||||
| #19 |
| CpG Island |
| Lung function | 2.373 | 7.94 × 10−10 | <0.001 |
| cg18588295 | CpG Island | “ | Triglyceride change | 0.317 | 8.07 × 10−6 | 0.021 | |
| cg08054032 | S Shore | “ | 0.557 | 1.10 × 10−8 | <0.001 | ||
|
| Open Sea | out | 1.530 | 5.99 × 10−6 | 0.018 |
Abbreviations: LGR6, Leucine-rich repeat containing G; HCG27, HLA complex group 27 (* RNA gene); RADIL, Rap associating with DIL domain; FGFR2, Fibroblast growth factor receptor 2; TMEM9B, TMEM9 domain family member B; FCGBP, Fc fragment of IgG binding protein; out, CpG locus is out of gene.
Overview of information related to other significant results in the exposed group when compared with the controls with 3 or more differently methylated CpG loci in the same gene.
| # Chrom. | CpG Locus | Island | Gene | Relevance or | log FC | ||
|---|---|---|---|---|---|---|---|
| #2 | cg18049933 | N Shore |
| uncharacterized | 0.588 | 4.20 × 10−5 | 0.048 |
| cg15237618 | N Shore | “ | 0.658 | 1.97 × 10−5 | 0.032 | ||
| cg23987493 | N Shore | “ | 0.671 | 7.68 × 10−6 | 0.021 | ||
| cg17611880 | N Shore |
| Transcription rec. | 0.473 | 3.89 × 10−5 | 0.046 | |
| cg18263335 | N Shore | “ | BMI | 0.852 | 2.37 × 10−6 | 0.012 | |
| cg27237671 | N Shore | “ | Body fat distrib. | 0.863 | 7.28 × 10−6 | 0.020 | |
| #4 | cg22541001 | S Shore |
| Signaling pathways | 0.370 | 3.87 × 10−7 | 0.004 |
| cg13587180 | S Shelf | “ | Tumor suppressor | 0.448 | 1.12 × 10−6 | 0.007 | |
| cg11065575 | S Shelf | “ | Cytokine level | 0.541 | 4.30 × 10−5 | 0.048 | |
| Type II diabetes | |||||||
| cg13365324 | Open Sea |
| Blood cell distrib. | 1.243 | 5.61 × 10−6 | 0.018 | |
| cg07973162 | Open Sea |
| Cholesterol | −1.171 | 7.00 × 10−6 | 0.020 | |
| cg07952421 | Open Sea | “ | Triglyceride | −1.103 | 1.88 × 10−5 | 0.032 | |
| Xenobiotics detox. | |||||||
| #8 | cg27405903 | Open Sea |
| Cognitive function | 0.457 | 3.36 × 10−6 | 0.014 |
| cg05986192 | Open Sea | “ | BMI | 0.641 | 2.07 × 10−6 | 0.011 | |
| cg17481116 | Open Sea | “ | 0.785 | 1.37 × 10−6 | 0.008 | ||
| #10 | cg08466030 | Open Sea |
| Gen expr. regul. | 0.397 | 2.70 × 10−5 | 0.038 |
| cg27040468 | Open Sea | “ | Signaling pathways | 0.660 | 1.07 × 10−6 | 0.007 | |
| cg12342675 | Open Sea | “ | Uric acid level | 0.987 | 8.73 × 10−7 | 0.006 | |
| #12 | cg27279351 | CpG Island |
| Intrac. transport | −0.305 | 1.62 × 10−7 | 0.002 |
| cg19946631 | N Shore | “ | Cellular senescence | −0.299 | 4.68 × 10−6 | 0.016 | |
| cg25284772 | N Shore | “ | Reticulocyte count | −0.241 | 1.24 × 10−6 | 0.008 | |
| Blood pressure | |||||||
| #13 | cg24545961 | S Shore |
| Signaling pathways | −1.498 | 5.45 × 10−8 | 0.001 |
| cg25702335 | S Shore | “ | −1.488 | 1.14 × 10−7 | 0.002 | ||
| cg24529736 | S Shore | “ | −0.801 | 1.26 × 10−7 | 0.002 | ||
| cg05709657 | S Shore | “ | −0.741 | 1.07 × 10−5 | 0.023 | ||
| #16 | cg04484415 | N Shore |
| Signaling pathways | 0.541 | 4.28 × 10−5 | 0.048 |
| cg05725404 | N Shore | “ | Apoptosis | 0.714 | 1.10 × 10−5 | 0.024 | |
| cg17457090 | N Shore | “ | QT interval | 0.616 | 3.47 × 10−5 | 0.043 | |
| Colorectal cancer | |||||||
| #19 | cg00857137 | CpG Island |
| Signaling pathways | 0.377 | 4.87 × 10−6 | 0.017 |
| cg26717563 | N Shore | “ | Blood cells count | 0.472 | 2.64 × 10−6 | 0.012 | |
| cg19334452 | CpG Island | “ | 0.533 | 1.66 × 10−6 | 0.009 | ||
| cg11374335 | N Shore |
| Cellular senescence | 0.383 | 2.90 × 10−11 | <0.001 | |
| cg06177396 | N Shore | “ | Transcr. regulator | 0.408 | 8.65 × 10−12 | <0.001 | |
| cg04928251 | N Shore | “ | Metal ion binding | 0.547 | 1.00 × 10−10 | <0.001 | |
| “ | BMI | ||||||
| Triglyceride | |||||||
| Blood cells count | |||||||
| #22 | cg07821417 | N Shelf |
| Blood cells count | 0.317 | 2.00 × 10−5 | 0.032 |
| cg16324072 | S Shelf | “ | Blood metab. level | 0.337 | 4.72 × 10−6 | 0.016 | |
| cg13823643 | S Shore | “ | Serum metab. level | 0.373 | 6.16 × 10−7 | 0.005 |
Abbreviations: LOC100996579, “uncharacterized gene”; TMEM18, Transmembrane protein 18; SHISA3, Shisa family member 3; UGT2B15/B17, UDP glucuronosyltransferase family 2 member B15/B17; SGCZ, Sarcoglycan zeta; BICC1, BicC family RNA binding protein 1; DYNLL1, Dynein light chain LC8 type 1; CLDN10, Claudin 10; NDRG4, NDRG family member 4; TLE2, TLE family member 2, transcriptional corepressor; WTIP, WT1 interacting protein; ARVCF, ARVCF delta catenin family member.
General characteristics of the exposed and control subjects.
| Characteristics Group | N | Mean ± SD | Median (Range) |
|
|---|---|---|---|---|
| Age (years) | ||||
| All | 40 | 42.1 ± 11.9 | 41 (21−72) | |
| Exposed | 20 | 39.3 ± 11 | 36.5 (24−65) | 0.129 |
| Controls | 20 | 45.0 ± 12.4 | 46 (21−72) | |
| Gender (M/F) | ||||
| All | 29/11 | N/A | N/A | |
| Exposed | 14/6 | N/A | N/A | 0.731 |
| Controls | 15/5 | N/A | N/A | |
| BMI (kg/m2) | ||||
| All | 40 | 26.4 ± 5.1 | 26 (19−38.9) | |
| Exposed | 20 | 26.8 ± 5.3 | 26.4 (19−36.7) | 0.655 |
| Controls | 20 | 26 ± 5 | 24.9 (20.2−38.9) |
Abbreviations: N, number of subjects; SD, standard deviation; M, males; F, females; N/A, not applicable; BMI, body mass index.
Exposure characteristics obtained from questionnaires.
| Characteristics Group | Mean ± SD | Median (Range) |
|
|---|---|---|---|
| NP exposure record | |||
| Exposed ( | |||
| Long-term (years) | 14.5 ± 9.2 | 12 (3−32) | |
| Common daily (min) | 115.5 ± 68.3 | 105 (60−270) | 0.028 |
| Short-term (min) | 154.5 ± 34.1 | 150 (120−240) |
Abbreviations: N, number of subjects; SD, standard deviation; p, comparison of common daily exposure (chronic) and short-term exposure in monitoring day (acute).